Correlation Between NervGen Pharma and Ryanair Holdings

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both NervGen Pharma and Ryanair Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NervGen Pharma and Ryanair Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NervGen Pharma Corp and Ryanair Holdings PLC, you can compare the effects of market volatilities on NervGen Pharma and Ryanair Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NervGen Pharma with a short position of Ryanair Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of NervGen Pharma and Ryanair Holdings.

Diversification Opportunities for NervGen Pharma and Ryanair Holdings

-0.21
  Correlation Coefficient

Very good diversification

The 3 months correlation between NervGen and Ryanair is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding NervGen Pharma Corp and Ryanair Holdings PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ryanair Holdings PLC and NervGen Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NervGen Pharma Corp are associated (or correlated) with Ryanair Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ryanair Holdings PLC has no effect on the direction of NervGen Pharma i.e., NervGen Pharma and Ryanair Holdings go up and down completely randomly.

Pair Corralation between NervGen Pharma and Ryanair Holdings

Assuming the 90 days horizon NervGen Pharma Corp is expected to generate 2.92 times more return on investment than Ryanair Holdings. However, NervGen Pharma is 2.92 times more volatile than Ryanair Holdings PLC. It trades about 0.04 of its potential returns per unit of risk. Ryanair Holdings PLC is currently generating about -0.09 per unit of risk. If you would invest  185.00  in NervGen Pharma Corp on August 29, 2024 and sell it today you would earn a total of  2.00  from holding NervGen Pharma Corp or generate 1.08% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

NervGen Pharma Corp  vs.  Ryanair Holdings PLC

 Performance 
       Timeline  
NervGen Pharma Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days NervGen Pharma Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, NervGen Pharma is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
Ryanair Holdings PLC 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Ryanair Holdings PLC are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, Ryanair Holdings is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

NervGen Pharma and Ryanair Holdings Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with NervGen Pharma and Ryanair Holdings

The main advantage of trading using opposite NervGen Pharma and Ryanair Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NervGen Pharma position performs unexpectedly, Ryanair Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ryanair Holdings will offset losses from the drop in Ryanair Holdings' long position.
The idea behind NervGen Pharma Corp and Ryanair Holdings PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope